Ten-year predicted coronary heart disease risk in HIV-infected men and women
Related Experiment Video
Updated: Jul 11, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Robert C Kaplan1, Lawrence A Kingsley, A Richey Sharrett
1Department of Epidemiology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. rkaplan@aecom.yu.edu
Insights
Highly active antiretroviral therapy (HAART) may impact coronary heart disease (CHD) risk in HIV patients. Overweight individuals and those with low income face higher CHD risk, necessitating targeted screening.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Highly active antiretroviral therapy (HAART) is a standard treatment for human immunodeficiency virus (HIV).
- Traditional vascular risk factors are known contributors to coronary heart disease (CHD).
- The combined impact of HAART and traditional risk factors on CHD risk in HIV-infected individuals requires further investigation.
Purpose of the Study:
- To estimate the predicted risk of coronary heart disease (CHD) in HIV-infected and HIV-uninfected adults.
- To identify factors associated with increased CHD risk among HIV-infected individuals.
- To assess the association between HAART regimens and CHD risk.
Main Methods:
- A cohort of HIV-infected and HIV-uninfected adults (men and women) was studied.
- Predicted CHD risk was calculated using established risk factors: age, sex, lipid levels, blood pressure, diabetes, and smoking status.
- Associations between HAART use (including specific regimens), body mass index (BMI), income level, and CHD risk were analyzed.
Main Results:
- A significant proportion of HIV-infected men (17%) and women (12%) had high predicted CHD risk.
- Compared to protease inhibitor-based HAART, HAART-naive individuals had significantly lower odds of moderate-to-high CHD risk (OR, 0.57).
- Elevated BMI and low income (<$10,000 annually) were independently associated with increased predicted CHD risk.
Conclusions:
- In HIV-infected adults, overweight status and low income are significant predictors of increased CHD risk, independent of antiretroviral drug exposure.
- These findings highlight the need for targeted vascular risk factor screening in HIV-infected individuals with these characteristics.
- Further research may explore the mechanisms linking HAART, metabolic changes, and cardiovascular outcomes in HIV.
Background:
Highly active antiretroviral therapy (HAART), in addition to traditional vascular risk factors, may affect coronary heart disease (CHD) risk in individuals with human immunodeficiency virus (HIV) infection.
Methods:
Among HIV-infected (931 men and 1455 women) and HIV-uninfected (1099 men and 576 women) adults, the predicted risk of CHD was estimated on the basis of age, sex, lipid and blood pressure levels, the presence of diabetes, and smoking status.
Results:
Among HIV-infected men, 2% had moderate predicted risk of CHD (10-year CHD risk, 15%-25%), and 17% had high predicted risk (10-year CHD risk of > or = 25% or diabetes). Among HIV-infected women, 2% had moderate predicted CHD risk, and 12% had high predicted CHD risk. Compared with users of protease inhibitor-based HAART, the adjusted odds ratio (OR) for moderate-to-high risk of CHD was significantly lower among HAART-naive individuals (OR, 0.57; 95% confidence interval [CI], 0.36-0.89). Users of HAART that was not protease inhibitor based (OR, 0.74; 95% CI, 0.53-1.01) and former HAART users (OR, 0.68; 95% CI, 0.46-1.03) were also less likely than users of protease inhibitor-based HAART to have moderate-to-high CHD risk, although 95% CIs overlapped the null. Low income was associated with increased likelihood of moderate-to-high CHD risk (for annual income < $10,000 vs. > $40,000: OR, 2.32; 95% CI, 1.51-3.56 ). Elevated body mass index (calculated as weight in kilograms divided by the square of height in meters) predicted increased likelihood of moderate-to-high CHD risk (for BMI of 18.5-24.9 vs. BMI of 25-30: OR, 1.41 [95% CI, 1.03-1.93]; for BMI of 18.5-24.9 vs. BMI > or = 30: OR, 1.79 [95% CI, 1.25-2.56]).
Conclusions:
Among HIV-infected adults, in addition to antiretroviral drug exposures, being overweight and having a low income level were associated with increased predicted CHD risk. This suggests a need to target HIV-infected men and women with these characteristics for vascular risk factor screening.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Hazard Ratio
For example, in a clinical trial evaluating a...
Relative Risk
Retrovirus Life Cycles
Sexually Transmitted Infections
Coronary Artery Disease I: Introduction

